CA
CA · CA · CA-DIN-02474565
LAPELGA
ATC L03AA13
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerAPOTEX INC
CountryCA (CA)
ATC codeL03AA13
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02474565",
"form": "SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L03AA13",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "96479",
"strengths": [
"6 MG"
],
"ahfs_class": null,
"substances": [
"PEGFILGRASTIM"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code L03AA13.
- 🇺🇸ARMLUPEGLupin Pharmaceuticals, Inc.
- DKCegfilaMundipharma Corporation (Ireland) Ltd.
- ISCegfilaMundipharma Corporation (Ireland) Limited
- FICegfilaMundipharma Corporation (Ireland) Limited
- PLCegfilaMundipharma Corporation (Ireland) Limited
- CZCEGFILAMundipharma Corporation (Ireland) Limited, Dublin
- BECegfila 6 mgMundipharma Corporation
- IECegfila 6 mg solution for injection in pre-filled syringeMundipharma Corporation (Ireland) Limited
Access this data programmatically
Query LAPELGA and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.